GlassScriptPhysician profile
Neil Sinha
NPI 1932433703
$9,160.11
in general payments reported to CMS, 2019-2025
45 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what 77% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,163 · 2020: $2,085 · 2021: $664 · 2022: $700 · 2023: $586 · 2024: $1,412 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,505 · Entertainment: $43.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,504.67 |
| Entertainment | $43.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,490.50 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $951.21 | 2019-2024 | Mild Device Kit |
| Medtronic Vascular, INC. | $935.14 | 2020 | |
| Medtronic, INC. | $863.77 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $628.90 | 2019-2020 | |
| Royal Biologics, INC. | $552.03 | 2019-2025 | |
| Nevro Corp. | $476.76 | 2019-2022 | |
| Stryker Corporation | $375.15 | 2021-2025 | |
| Nuvasive, INC. | $237.24 | 2020 | |
| Saluda Medical Americas, INC. | $217.75 | 2024 | Evoke |
| Flowonix Medical Incorporated | $195.01 | 2019 | |
| Collegium Pharmaceutical, INC. | $192.30 | 2019-2024 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.38 | 2019-2025 | Relistor |
| Foundation Fusion Solutions, LLC | $183.71 | 2022-2025 | |
| Si-Bone, INC. | $178.47 | 2019-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.91 | 2022-2025 | Botox |
| Depuy Synthes Sales INC. | $148.97 | 2019-2025 | Rigidloop, Monovisc, Orthovisc |
| Painteq LLC | $144.23 | 2024 | Painteq |
| Vertiflex, INC. | $143.31 | 2019 | |
| Nalu Medical, INC. | $102.05 | 2024 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $71.90 | 2019-2020 | |
| Biotronik Nro, INC. | $63.29 | 2024-2025 | Prospera |
| Forte Bio-Pharma LLC | $60.93 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Redhill Biopharma INC. | $54.15 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $49.39 | 2020 | |
| Fidia Pharma USA INC. | $46.80 | 2019-2025 | Triluron, Hymovis |
| Zyla Life Sciences, INC. | $42.94 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $42.71 | 2022-2023 | Ztlido |
| Tersera Therapeutics LLC | $38.45 | 2019 | |
| Virtus Pharmaceuticals LLC | $34.93 | 2020-2024 | Levorphanol Tartrate |
| Astrazeneca Pharmaceuticals LP | $30.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.49 | 2023 | Seglentis |
| Pfizer INC. | $28.67 | 2019 | |
| Almatica Pharma LLC | $27.88 | 2022 | |
| Curonix LLC | $19.82 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Otsuka America Pharmaceutical, INC. | $17.59 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.98 | 2023 | Iovera, Zilretta |
| Daiichi Sankyo INC. | $14.92 | 2019 | |
| Pacira Therapeutics, INC. | $14.78 | 2019 | |
| Horizon Therapeutics Plc | $14.29 | 2019 | |
| Allergan, INC. | $14.24 | 2019 | |
| Averitas Pharma INC. | $13.34 | 2023 | Qutenza |
| Shionogi INC | $13.12 | 2019 | |
| Ibsa Pharma INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.